Intervention

Interleukin-12

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 6 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials6
Recruiting0
Common conditions5
Lead sponsors shown2
Advertisement

Clinical trials

6 shown
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12NCT00622401 · 2009-12-01
TERMINATED
Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex InfectionNCT00001763 · 1998-04-01
COMPLETED
Safety of the Candidate Vaccine C4-V3 Alone or With Interleukin-12 (IL-12) in HIV-Infected Patients Receiving Effective Anti-HIV Drug TherapyNCT00005779
COMPLETED
A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive PatientsNCT00000896
COMPLETED
A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3NCT00000857
COMPLETED
Treatment of Chronic Cryptosporidiosis in AIDS PatientsNCT00001128
TERMINATED

Trial status mix

COMPLETED4
TERMINATED2

Phase mix

PHASE14
NA2
PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.